Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kanta Subbarao

Showing results (141-150 of 300) with videos related to

Pageof 30
Sort By:
Journal of Virology|April 29, 2005
Evaluation of human monoclonal antibody 80R for immunoprophylaxis of severe acute respiratory syndrome by an animal study, epitope mapping, and analysis of spike variantsJianhua Sui, Wenhui Li, Anjeanette Roberts, et al.
Journal of Virology|November 11, 2011
Molecular determinants of severe acute respiratory syndrome coronavirus pathogenesis and virulence in young and aged mouse models of human diseaseMatthew Frieman, Boyd Yount, Sudhakar Agnihothram, et al.
Paediatric Respiratory Reviews|March 1, 2022
Age-related differences in SARS-CoV-2 binding factors: An explanation for reduced susceptibility to severe COVID-19 among children?Thomas Abrehart, Randy Suryadinata, Conor McCafferty, et al.
Viruses|August 28, 2021
Prevalence of Neutralising Antibodies to HCoV-NL63 in Healthy Adults in AustraliaSean A Lynch, Kanta Subbarao, Siddhartha Mahanty, et al.
Journal of Virology|August 21, 2009
A single-amino-acid substitution in a polymerase protein of an H5N1 influenza virus is associated with systemic infection and impaired T-cell activation in miceJamie L Fornek, Laura Gillim-Ross, Celia Santos, et al.
Plos Medicine|April 22, 2009
Antigenic fingerprinting of H5N1 avian influenza using convalescent sera and monoclonal antibodies reveals potential vaccine and diagnostic targetsSurender Khurana, Amorsolo L Suguitan, Yonaira Rivera, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|September 14, 2023
The re-emergence of influenza following the COVID-19 pandemic in Victoria, Australia, 2021 to 2022Catherine Ga Pendrey, Janet Strachan, Heidi Peck, et al.
Emerging Infectious Diseases|July 27, 2002
DNA vaccine expressing conserved influenza virus proteins protective against H5N1 challenge infection in miceSuzanne L Epstein, Terrence M Tumpey, Julia A Misplon, et al.
Virology|December 17, 2002
Reappearance and global spread of variants of influenza B/Victoria/2/87 lineage viruses in the 2000-2001 and 2001-2002 seasonsMichael W Shaw, Xiyan Xu, Yan Li, et al.
Virus Research|May 28, 2004
Reassortment and evolution of current human influenza A and B virusesXiyan Xu, Stephen E Lindstrom, Michael W Shaw, et al.
Pageof 30

Showing results (141-150 of 300) with videos related to

Sort By:
Pageof 30
Journal of Virology|April 29, 2005
Evaluation of human monoclonal antibody 80R for immunoprophylaxis of severe acute respiratory syndrome by an animal study, epitope mapping, and analysis of spike variantsJianhua Sui, Wenhui Li, Anjeanette Roberts, et al.
Journal of Virology|November 11, 2011
Molecular determinants of severe acute respiratory syndrome coronavirus pathogenesis and virulence in young and aged mouse models of human diseaseMatthew Frieman, Boyd Yount, Sudhakar Agnihothram, et al.
Paediatric Respiratory Reviews|March 1, 2022
Age-related differences in SARS-CoV-2 binding factors: An explanation for reduced susceptibility to severe COVID-19 among children?Thomas Abrehart, Randy Suryadinata, Conor McCafferty, et al.
Viruses|August 28, 2021
Prevalence of Neutralising Antibodies to HCoV-NL63 in Healthy Adults in AustraliaSean A Lynch, Kanta Subbarao, Siddhartha Mahanty, et al.
Journal of Virology|August 21, 2009
A single-amino-acid substitution in a polymerase protein of an H5N1 influenza virus is associated with systemic infection and impaired T-cell activation in miceJamie L Fornek, Laura Gillim-Ross, Celia Santos, et al.
Plos Medicine|April 22, 2009
Antigenic fingerprinting of H5N1 avian influenza using convalescent sera and monoclonal antibodies reveals potential vaccine and diagnostic targetsSurender Khurana, Amorsolo L Suguitan, Yonaira Rivera, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|September 14, 2023
The re-emergence of influenza following the COVID-19 pandemic in Victoria, Australia, 2021 to 2022Catherine Ga Pendrey, Janet Strachan, Heidi Peck, et al.
Emerging Infectious Diseases|July 27, 2002
DNA vaccine expressing conserved influenza virus proteins protective against H5N1 challenge infection in miceSuzanne L Epstein, Terrence M Tumpey, Julia A Misplon, et al.
Virology|December 17, 2002
Reappearance and global spread of variants of influenza B/Victoria/2/87 lineage viruses in the 2000-2001 and 2001-2002 seasonsMichael W Shaw, Xiyan Xu, Yan Li, et al.
Virus Research|May 28, 2004
Reassortment and evolution of current human influenza A and B virusesXiyan Xu, Stephen E Lindstrom, Michael W Shaw, et al.
Pageof 30